Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

An investigation of Ph(1) chromosome in Chronic Myeloid Leukemia patients with different treatment modalities and hematological features.

Chattopadhyay K, Kar B.

Indian J Hum Genet. 2012 May;18(2):229-32. doi: 10.4103/0971-6866.100778.

PMID:
23162301
[PubMed]
Free PMC Article
2.

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Johansson B, Fioretos T, Mitelman F.

Acta Haematol. 2002;107(2):76-94. Review.

PMID:
11919388
[PubMed - indexed for MEDLINE]
3.

[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].

Liu XL, Zhou SY, Du QF, Zheng WY, Zhang S, Song LL, Xu B, Liu QF, Meng FY.

Ai Zheng. 2004 Apr;23(4):421-5. Chinese.

PMID:
15087031
[PubMed - indexed for MEDLINE]
4.

Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.

van der Plas DC, Grosveld G, Hagemeijer A.

Cancer Genet Cytogenet. 1991 Apr;52(2):143-56. Review.

PMID:
2021916
[PubMed - indexed for MEDLINE]
5.

[Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].

Hong H, Qiu JY, Lai YY, Shi Y, He Q, Dang H, Lu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):269-73. Chinese.

PMID:
12844411
[PubMed - indexed for MEDLINE]
6.

Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.

Oshimura M, Ohyashiki K, Terada H, Takaku F, Tonomura A.

Cancer Genet Cytogenet. 1982 Mar;5(3):187-201.

PMID:
6950809
[PubMed - indexed for MEDLINE]
7.

Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.

Bennour A, Bellâaj H, Ben Youssef Y, Elloumi M, Khelif A, Saad A, Sennana H.

J Cancer Res Clin Oncol. 2011 Sep;137(9):1329-36. doi: 10.1007/s00432-011-1002-4. Epub 2011 Jul 8.

PMID:
21739181
[PubMed - indexed for MEDLINE]
8.

Cytogenetic investigation in chronic myeloid leukemia: study from an Indian population.

Chavan D, Ahmad F, Iyer P, Dalvi R, Kulkarni A, Mandava S, Das BR.

Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):423-6.

PMID:
17059336
[PubMed - indexed for MEDLINE]
Free Article
9.

Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.

Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ.

Blood. 1995 Sep 15;86(6):2343-9.

PMID:
7662980
[PubMed - indexed for MEDLINE]
Free Article
10.

[Glivec in combination with HA regimen for treatment of 20 patients with Ph chromosome positive acute leukemia].

Meng FY, Zheng WY, Liu XL, Song LL, Xu B, Zhang Y, Huang F.

Ai Zheng. 2003 Aug;22(8):840-3. Chinese.

PMID:
12917031
[PubMed - indexed for MEDLINE]
11.

Imatinib: a review of its use in chronic myeloid leukaemia.

Moen MD, McKeage K, Plosker GL, Siddiqui MA.

Drugs. 2007;67(2):299-320. Review.

PMID:
17284091
[PubMed - indexed for MEDLINE]
12.

A novel cytogenetic abnormality t(7;8)(p11.2:q11.2) and a four-way Philadelphia translocation in an imatinib mesylate-resistant chronic myeloid leukemia patient.

Al-Achkar W, Aljapawe A, Almedani S, Liehr T, Wafa A.

Oncol Lett. 2013 Feb;5(2):617-620. Epub 2012 Nov 21.

PMID:
23420612
[PubMed]
Free PMC Article
13.

[Bone marrow morphologic features in patients treated with imatinib for Philadelphia chromosome positive chronic myeloid leukemia].

Jiang Q, Chen SS, Jiang B, Jiang H, Shi HL, Lu Y, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2004 Mar;25(3):158-62. Chinese.

PMID:
15182585
[PubMed - indexed for MEDLINE]
14.

[Molecular analysis of chronic Philadelphia chromosome negative myeloid leukemia: study of 6 cases].

Cervantes F, Urbano-Ispizua A, Pujades A, Bosch F, Vives-Corrons JL, Montserrat E, Rozman C.

Med Clin (Barc). 1992 Sep 19;99(8):286-8. Spanish.

PMID:
1453821
[PubMed - indexed for MEDLINE]
15.

Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.

Bacher U, Haferlach T, Hiddemann W, Schnittger S, Kern W, Schoch C.

Cancer Genet Cytogenet. 2005 Feb;157(1):53-61.

PMID:
15676148
[PubMed - indexed for MEDLINE]
16.

[Karyotype analysis in 119 patients with chronic myeloid leukemia at blast crisis].

Zhu Y, Li JY, Pan JL, Wu W, Qiu HR, Wu YF, Yang H, Zhang JF, Chen LJ, Xue YQ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1074-8. Chinese.

PMID:
17204167
[PubMed - indexed for MEDLINE]
17.

Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.

Su XY, Wong N, Cao Q, Yu LZ, Niu C, Wickham N, Johnson PJ, Chen Z, Chen SJ.

Cancer Genet Cytogenet. 1999 Jan 1;108(1):6-12.

PMID:
9973917
[PubMed - indexed for MEDLINE]
18.

Chromosome abnormalities in chronic myeloid leukemia in children.

Puchkova GP, Prigogina EL, Fleischmann EW, Drosdova TS, Mayakova SA, Peterson IS.

Hum Genet. 1983;64(3):257-62.

PMID:
6576982
[PubMed - indexed for MEDLINE]
19.

Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.

Morris CM.

Methods Mol Biol. 2011;730:33-61. doi: 10.1007/978-1-61779-074-4_4.

PMID:
21431633
[PubMed - indexed for MEDLINE]
20.

Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML).

Haas OA, Schwarzmeier JD, Nacheva E, Fischer P, Paietta E.

Blut. 1984 Jan;48(1):33-43.

PMID:
6580930
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk